Search

Author/Creator Weiss, Brendan M.

1. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging. Issue 5 (3rd May 2016)

Authors:
Bhutani, Manisha; Turkbey, Baris; Tan, Esther; Korde, Neha; Kwok, Mary; Manasanch, Elisabet E.; Tageja, Nishant; Mailankody, Sham; Roschewski, Mark; Mulquin, Marcia; Carpenter, Ashley; Lamping, Elizabeth; Minter, Alex R.; Weiss, Brendan M.; Mena, Esther; Lindenberg, Liza; Calvo, Katherine R.; Mar...
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 5(2016:May)
Page Start:
1114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019. (23rd July 2021)

Authors:
Hester, Laura L.; Gifkins, Dina M.; M. Bellew, Kevin; Vermeulen, Jessica; Schecter, Jordan M.; Strony, John; Dishy, Victor; Weiss, Brendan M.
Journal:
European journal of haematology
Issue:
Volume 107:Number 4(2021)
Page Start:
428
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. Issue 6 (30th March 2022)

Authors:
Sanchorawala, Vaishali; Palladini, Giovanni; Minnema, Monique C.; Jaccard, Arnaud; Lee, Hans C.; Gibbs, Simon; Mollee, Peter; Venner, Christopher; Lu, Jin; Schönland, Stefan; Gatt, Moshe; Suzuki, Kenshi; Kim, Kihyun; Cibeira, María Teresa; Beksac, Meral; Libby, Edward; Valent, Jason; Hungria, Van...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 6(2022)
Page Start:
719
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis. (28th November 2021)

Authors:
Luo, Man (Melody); Zhu, Peijuan (Penny); Nnane, Ivo; Xiong, Yuan; Merlini, Giampaolo; Comenzo, Raymond L; Kastritis, Efstathios; Wechalekar, Ashutosh D.; Weiss, Brendan M.; Tran, NamPhuong; Qin, Xiang; Vermeulen, Jessica; Sharma, Amarnath; Sun, Yu‐Nien; Zhou, Honghui
Journal:
Journal of clinical pharmacology
Issue:
Volume 62:Number 5(2022)
Page Start:
656
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Proteasome inhibitor associated thrombotic microangiopathy. Issue 9 (4th July 2016)

Authors:
Yui, Jennifer C.; Van Keer, Jan; Weiss, Brendan M.; Waxman, Adam J.; Palmer, Matthew B.; D'Agati, Vivette D.; Kastritis, Efstathios; Dimopoulos, Meletios A.; Vij, Ravi; Bansal, Dhruv; Dingli, David; Nasr, Samih H.; Leung, Nelson
Journal:
American journal of hematology
Issue:
Volume 91:Issue 9(2016:Sep.)
Page Start:
E348
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗